These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours. Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485 [TBL] [Abstract][Full Text] [Related]
12. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. Etrych T; Jelínková M; Ríhová B; Ulbrich K J Control Release; 2001 May; 73(1):89-102. PubMed ID: 11337062 [TBL] [Abstract][Full Text] [Related]
13. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia. Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020 [TBL] [Abstract][Full Text] [Related]
14. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma. O'Hare KB; Duncan R; Strohalm J; Ulbrich K; Kopeckova P J Drug Target; 1993; 1(3):217-29. PubMed ID: 8069563 [TBL] [Abstract][Full Text] [Related]
15. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin. Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482 [TBL] [Abstract][Full Text] [Related]
16. Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates. Kasuya Y; Lu ZR; Kopecková P; Tabibi SE; Kopecek J Pharm Res; 2002 Feb; 19(2):115-23. PubMed ID: 11883637 [TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells. Hongrapipat J; Kopecková P; Liu J; Prakongpan S; Kopecek J Mol Pharm; 2008; 5(5):696-709. PubMed ID: 18729468 [TBL] [Abstract][Full Text] [Related]
18. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
19. Backbone degradable multiblock N-(2-hydroxypropyl)methacrylamide copolymer conjugates via reversible addition-fragmentation chain transfer polymerization and thiol-ene coupling reaction. Pan H; Yang J; Kopecková P; Kopecek J Biomacromolecules; 2011 Jan; 12(1):247-52. PubMed ID: 21158387 [TBL] [Abstract][Full Text] [Related]
20. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance. Tijerina M; Fowers KD; Kopecková P; Kopecek J Biomaterials; 2000 Nov; 21(21):2203-10. PubMed ID: 10985494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]